MHRA announces consultation on improved safety for high risk in vitro diagnostic devices  

The Medicines and Healthcare products Regulatory Agency (MHRA) has today (21 May 2024) launched a four-week consultation which will support improved safety for certain high risk in vitro diagnostic (IVD) devices.

Follow this news feed: